Hypertension (high blood pressure) decisions — 2025

The Veteran is granted a total disability rating based on individual unemployability and special monthly compensation from May 5, 2019.

The Board denied an increased rating for the Veteran's acquired psychiatric disorder and remanded claims for service connection for hypertension, erectile dysfunction, and TDIU.

The Board granted service connection for hypertension, and assigned ratings of 40 percent and 30 percent for diabetic peripheral neuropathy of the right and left upper extremity radicular nerve groups, respectively. The appeal for an increased evaluation of diabetes was denied.

The Board remands the claim for service connection for a cardiovascular disorder, other than supraventricular arrhythmia, to include hypertension, left ventricular hypertrophy and diastolic dysfunction, on a direct basis or as secondary to service-connected supraventricular arrhythmia.

The Board denied service connection for various disabilities, including diabetes mellitus, lung disability, bilateral foot disability, stomach disability (GERD), colon disability, prostate disability, foot rash, heart disability, and hypertension.

The Board remands the claims for service connection for chronic kidney disease, CML, hypertension, non-allergic rhinitis, and hypothyroidism to obtain a VA examination that addresses the Veteran's competent and credible statements of exposure to fumes as causing his conditions.

The appeal for service connection for hypertension was withdrawn by the Veteran.

The Board remands all claims for further development, including obtaining outstanding VA treatment records and scheduling the Veteran for examinations to determine the severity of his bilateral shin splints and any right knee or lower leg disorder other than his service-connected right shin splint.

The Board granted service connection for diabetes mellitus, type II and hypertension due to presumed exposure to herbicide agents during the Veteran's service in Thailand. The claim for left leg neuropathy was denied.

The Board granted an initial disability rating of 30 percent for service-connected headaches, effective from November 1, 2021 to April 11, 2023.

The Board granted service connection for hypertension and sleep apnea, finding that both conditions are secondary to the Veteran's service-connected PTSD and social anxiety disorder.

The Board denied the Veteran's appeal for an initial compensable rating for hypertension, as there was no evidence of diastolic pressure predominantly 100 or more or systolic pressure predominantly 160 or more.

The Board granted service connection for ischemic heart disease and hypertension, both presumed to have resulted from the Veteran's conceded herbicide agent exposure during active service in the Republic of Vietnam.

The Board denied service connection for loss of teeth, hypertension, diabetes mellitus type II with cataracts, and posttraumatic stress disorder. The claims were remanded for further consideration.

The Board denied service connection for hypertension, vertigo, and a head injury as no new and relevant evidence was received to warrant readjudication of the claims.

The Board granted service connection for obstructive sleep apnea and an initial rating of 20 percent for degenerative arthritis of the cervical spine (neck). The remaining claims were remanded for further development.

The Board granted service connection for hypertension as it was caused by the Veteran's service-connected right foot hallux valgus, with obesity serving as an intermediate step.

The Board dismissed the appeals for initial disability ratings and remanded claims related to diabetes mellitus, hypertension, and diabetic neuropathy due to a lack of evidence.

The Board remands the claims for service connection for myelodysplastic syndrome and hypertension to ensure that the record is fully developed.

The Board granted service connection for sleep disturbances, diagnosed as obstructive sleep apnea and dismissed the appeal regarding pseudofolliculitis barbae. The claims for chronic fatigue syndrome and hypertension were denied.